Bafna Pharma.

{
  "main_header": {
    "sid": 852453,
    "name": "Bafna Pharma.",
    "stock_name": "Bafna Pharma.",
    "full_name": "Bafna Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/bafna-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "229.05",
    "chg": 4.45,
    "chgp": "1.98%",
    "dir": 1,
    "prev_price": "224.60",
    "mcapval": "531.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532989,
    "symbol": "BAFNAPH",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE878I01022",
    "curr_date": "Jul 17, 03:30 PM",
    "curr_time": "20:08 PM",
    "last_traded_at": "Jul 17, 03:30 PM IST",
    "bse_nse_vol": "13.07 k",
    "exc_status": "Active",
    "traded_date": "Jul 17, 2026",
    "traded_date_str": "2026 07 17",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bafna-pharma-852453-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Bafna Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bafna-pharmaceuticals-ltd-is-rated-sell-4107107",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BafnaPharmaceut_mojoScore_4107107.png",
        "date": "2026-07-18 10:10:06",
        "description": "Bafna Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Bafna Pharmaceuticals Gains 5.88%: 6 Key Factors Driving the Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-gains-588-6-key-factors-driving-the-rally-4088812",
        "imagepath": "",
        "date": "2026-07-04 15:03:03",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>29 Jun:</strong> Upper circuit hit at Rs.204.00 amid strong buying pressure</p>\n                    <p><strong>30 Jun:</strong> New 52-week high at Rs.218.7 and upper circuit at Rs.214.63</p>\n                    <p><strong>1 Jul:</strong> New 52-week high at Rs.229.6 and upper circuit at Rs.225.36</p>\n                    <p><strong>2 Jul:</strong> New 52-week high at Rs.234.15</p>\n                    <p><strong>3 Jul:</strong> Week closes at Rs.220.55 (-2.00% on day)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.208.30</div></div>\n                    <..."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bafna-pharmaceuticals-ltd-is-rated-sell-4088424",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BafnaPharmaceut_mojoScore_4088424.png",
        "date": "2026-07-04 10:10:04",
        "description": "Bafna Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Bafna Pharmaceuticals Ltd to 52-Week High of Rs 234.15",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-new-52-week-high-at-rs23415-4084884",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BafnaPharmaceut_priceRelatedfactors_4084884.png",
        "date": "2026-07-02 10:36:27",
        "description": "Surging to a new 52-week and all-time high of Rs 234.15 on 2 Jul 2026, Bafna Pharmaceuticals Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market with a sustained rally that has extended over nine consecutive trading sessions."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-upper-circuit-surges-5-amid-strong-buying-pressure-4081378",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BafnaPharmaceut_stocks_hitting_upper_circuit_4081378.png",
        "date": "2026-07-01 10:00:20",
        "description": "At Rs 225.36, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bafna Pharmaceuticals Ltd locked at its upper circuit of 5.0% on 30 Jun 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Bafna Pharmaceuticals Ltd to 52-Week High of Rs 229.6",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-new-52-week-high-at-rs2296-4081226",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BafnaPharmaceut_priceRelatedfactors_4081226.png",
        "date": "2026-07-01 09:51:17",
        "description": "Surging to an intraday peak of Rs 229.6 on 1 Jul 2026, Bafna Pharmaceuticals Ltd has marked a significant milestone by reaching a fresh 52-week high. This rally, driven by a powerful alignment of technical indicators and sustained price momentum, underscores the stock’s robust upward trajectory over the past year."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 5.0% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-upper-circuit-amid-strong-buying-momentum-4078567",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BafnaPharmaceut_stocks_hitting_upper_circuit_4078567.png",
        "date": "2026-06-30 10:00:17",
        "description": "At Rs 214.63, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bafna Pharmaceuticals Ltd locked at its upper circuit of 5.0% on 30 Jun 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Bafna Pharmaceuticals Ltd to 52-Week High of Rs 218.7",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-new-52-week-high-at-rs2187-4078453",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BafnaPharmaceut_priceRelatedfactors_4078453.png",
        "date": "2026-06-30 09:53:41",
        "description": "Surging past its previous peaks, Bafna Pharmaceuticals Ltd touched a fresh 52-week high of Rs 218.7 on 30 Jun 2026, marking a remarkable rally from its 52-week low of Rs 77.01. This milestone caps a seven-day winning streak that has propelled the stock up by nearly 40%, underscoring a powerful momentum shift in the micro-cap pharmaceutical player."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-upper-circuit-amid-strong-buying-pressure-4076695",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BafnaPharmaceut_stocks_hitting_upper_circuit_4076695.png",
        "date": "2026-06-29 10:00:21",
        "description": "At Rs 204.41, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bafna Pharmaceuticals Ltd locked at its upper circuit of 5% on 29 Jun 2026, with buyers queuing and no sellers willing to part with shares."
      }
    ],
    "total": 351,
    "sid": "852453",
    "stock_news_url": "https://www.marketsmojo.com/news/bafna-pharmaceuticals-852453"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "09-Jul-2026",
      "details": "Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended June 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Jun-2026",
      "details": "Intimation for Closure of Trading Window",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Retirement",
      "datetime": "22-Jun-2026",
      "details": "Intimation for retirement of Mr. Navin Kumar (DIN: 08778662) as an Independent Director of the Company upon completion of his first term with effect from close of business hours on June 22 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bafna Pharmaceuticals Ltd has declared <strong>6%</strong> dividend, ex-date: 19 Sep 13",
          "dt": "2013-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Bafna Pharmaceuticals Ltd is Rated Sell

2026-07-18 10:10:06

Bafna Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Bafna Pharmaceuticals Gains 5.88%: 6 Key Factors Driving the Rally

2026-07-04 15:03:03

Key Events This Week

29 Jun: Upper circuit hit at Rs.204.00 amid strong buying pressure

30 Jun: New 52-week high at Rs.218.7 and upper circuit at Rs.214.63

1 Jul: New 52-week high at Rs.229.6 and upper circuit at Rs.225.36

2 Jul: New 52-week high at Rs.234.15

3 Jul: Week closes at Rs.220.55 (-2.00% on day)

Week Open

Rs.208.30

<...

Read full news article

Bafna Pharmaceuticals Ltd is Rated Sell

2026-07-04 10:10:04

Bafna Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Broad-Based Technical Strength Lifts Bafna Pharmaceuticals Ltd to 52-Week High of Rs 234.15

2026-07-02 10:36:27

Surging to a new 52-week and all-time high of Rs 234.15 on 2 Jul 2026, Bafna Pharmaceuticals Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market with a sustained rally that has extended over nine consecutive trading sessions.

Read full news article

Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent

2026-07-01 10:00:20

At Rs 225.36, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bafna Pharmaceuticals Ltd locked at its upper circuit of 5.0% on 30 Jun 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Broad-Based Technical Strength Lifts Bafna Pharmaceuticals Ltd to 52-Week High of Rs 229.6

2026-07-01 09:51:17

Surging to an intraday peak of Rs 229.6 on 1 Jul 2026, Bafna Pharmaceuticals Ltd has marked a significant milestone by reaching a fresh 52-week high. This rally, driven by a powerful alignment of technical indicators and sustained price momentum, underscores the stock’s robust upward trajectory over the past year.

Read full news article

Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 5.0% Gain — Buyers Queue, Sellers Absent

2026-06-30 10:00:17

At Rs 214.63, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bafna Pharmaceuticals Ltd locked at its upper circuit of 5.0% on 30 Jun 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Broad-Based Technical Strength Lifts Bafna Pharmaceuticals Ltd to 52-Week High of Rs 218.7

2026-06-30 09:53:41

Surging past its previous peaks, Bafna Pharmaceuticals Ltd touched a fresh 52-week high of Rs 218.7 on 30 Jun 2026, marking a remarkable rally from its 52-week low of Rs 77.01. This milestone caps a seven-day winning streak that has propelled the stock up by nearly 40%, underscoring a powerful momentum shift in the micro-cap pharmaceutical player.

Read full news article

Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent

2026-06-29 10:00:21

At Rs 204.41, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bafna Pharmaceuticals Ltd locked at its upper circuit of 5% on 29 Jun 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

View All News